Blog

Headlines: CRISPR Ethics. Life Science Sector Deal Announced. CRISPR: Chinese research scientist, Dr He Jiankui, has claimed that twin girls born in November were genetically altered using CRISPR. If true, these are the first humans born with CRISPR-edited DNA that can be inherited by their children. The DNA coding for the CCR5 cell receptor, which […]

read more

UKI2S has privileged access to emerging research across many of the UK’s science and technology campuses. This access allows us to seek out and support innovative young companies through our unique source of patient capital funding, helping to bring in outside investment and guide young companies in various fields. One such laboratory is the Babraham […]

read more

UKI2S announced in August the successful exit of its portfolio company Quethera. Acquired by Japanese pharma giant Astellas for up to £85 million, the deal sees Quethera’s novel ophthalmic treatment program continue under the new parent. How did this successful exit come about in under three years since first raising funds? Quethera was founded by […]

read more

1 2 3 4